© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 103.12% of CBAY shares are held by financial institutions. DEUTSCHE BANK AG\ is the top corporate investor, holding 0 shares valued at -. A 0% stake in CymaBay Therapeutics, Inc. is owned by the company. US BANCORP \DE\ owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
Among the CBAY insiders holding of 0.52% of the stake in company, SHAH SUJAL, Chief Executive Officer, holds the largest shares of 171.3K. EMSTER KURT VON, director, is the second largest CBAY insider with ownership of 90K shares. WILLS ROBERT JAMES, director, stands third with possession of 26.5K shares of that stake.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own CBAY shares is 275, representing 103.12% of the company's common stock.
DEUTSCHE BANK AG\, in the last quarter, reduced its stake in CBAY by -100% restricting it's holding to 0 shares of worth nearly -. US BANCORP \DE\ also lessened -100% of the CBAY shares from its portfolio, reducing its holding to 0 shares of worth -. PRICE T ROWE ASSOCIATES INC /MD/ also shunned CBAY shares holding by -100% last quarter which brought its holding to 0 shares worth -.
As per its latest 13F filing, NORTHERN TRUST CORP increased its stake in CBAY by 8.2% in the last quarter. The institutional holder raised its holding to 1.09 million shares having worth more than $25.75M. EMERALD ADVISERS, LLC also added 8.63% more shares of CBAY to its portfolio, raising its holding to 1.07 million shares of worth $25.24M. MORGAN STANLEY also increased its CBAY shares holding by 88.57% which brought its holding to 956.95 thousand shares worth $22.60M.
The insider with the most stakes in CBAY is Shah Sujal , Chief Executive Officer at the company. Additionally, CBAY stock is highly held by director EMSTER KURT VON and director Wills Robert James among others.
Company executives, directors, and other insiders own 0.52% percent of CymaBay Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which CBAY insiders have sold stock, totaling 0 shares. Insiders that have sold shares include DORLING JANET, MCWHERTER CHARLES, and MENOLD DANIEL.
There have been 0 transaction(s) during the past 6-months in which CymaBay Therapeutics, Inc. insiders have bought stock, totalling 0 shares
Around 0 CymaBay Therapeutics, Inc. shares are held by insiders, which represents about 0.52% of CBAY stock.
CBAY Chief Executive Officer, Shah Sujal holds the largest portfolio of the company's shares. CBAY shares owned by Shah total nearly 171.3 thousand.
DEUTSCHE BANK AG\ is the largest institutional owner in CBAY which holds 0 shares worth - or 0% of the total CBAY shares outstanding followed by US BANCORP \DE\ with ownership of 0 shares representing 0% of the CBAY ownership. PRICE T ROWE ASSOCIATES INC /MD/ is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the CBAY is concerned, it is a stock which is not optionable.
Number of CBAY shares short is 5.85M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, 114.78M shares of CBAY are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, CBAY has 96.64M shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for CBAY is 0.84.